professionals about the promotion and advertising of FDA-approved lasers used during refractive procedures, including laser-assisted in-situ keratomileusis (LASIK). This letter implemented an April 2008, FDA Ophthalmic Devices Panel public…
Quote saved.
Login to quote this blog
Failed to save quote. Please try again later.
You cannot quote because this article is private.